Found 10 matching trials
CAR-T Cell Therapy for Desensitization in Kidney Transplantation PHASE1 This research study is for people who have been waiting for a kidney transp...
Show More Location
Massachusetts General Hospital: Transplantation (Site #: 71107)
Learn More & Join Trial
Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL PHASE2 This is a phase 2 study to evaluate humanized CD19 redirected autologous T ...
Show More Location
Children's Hospital of Pennsylvania
Learn More & Join Trial
Co-administration of CART22-65s and huCART19 for B-ALL PHASE1 This study will evaluate the safety and efficacy of administering two CAR T...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy PHASE1 This is a pilot study to evaluate humanized CD19 redirected autologous T ce...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy) PHASE1 This study will determine the safety and efficacy of moving to a second-gen...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
CART22 Alone or in Combination With huCART19 for ALL PHASE1 This is a single center, open-label, phase 1 study to determine the safety ...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
huCART19-IL18 in CD19+ Cancers PHASE1 The purpose of this study is to evaluate the safety and feasibility of huCA...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
Retreatment With CTL019/CTL119 PHASE1 This research study is designed to evaluate the effects of retreatment with...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma PHASE1 This is an open-label, phase 1 study to assess the safety, pharmacodynamics...
Show More Status
Active Not Recruiting
Location
Univ. of Pennsylvania
Learn More & Join Trial
huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma PHASE1 This is a phase 1, open-label study to evaluate the feasibility, safety and...
Show More Location
University of Pennsylvania
Learn More & Join Trial